5 Best Spinal Muscular Atrophy Treatment Clinics in Turkey — AUD Prices

Turkey provides disease-modifying treatments for Spinal Muscular Atrophy. These include Nusinersen (Spinraza), Risdiplam (Evrysdi), and Onasemnogene abeparvovec (Zolgensma). Specialists like Dr Siar Dursun at Medipol University Pendik Hospital manage these protocols. Availability depends on specific genetic criteria and Ministry of Health approval.

• Nusinersen (Spinraza): Administered via spinal injection for SMA Types 1, 2, and 3.
• Risdiplam (Evrysdi): Available as an oral liquid for patients with confirmed genetic eligibility.
• Zolgensma access: This gene therapy usually requires private funding or specific legal authorisation.
• Newborn screening: National programs identify SMA early to begin treatment before symptoms progress.

Bookimed Expert Insight: Many centres focus on drug delivery. However, leading Istanbul facilities like Memorial Şişli Hospital combine JCI-accredited care with genetic diagnostics. Dr Siar Dursun's practice is at a university hospital with 21 newborn intensive care units. This is a significant advantage. This setup provides infants with immediate, high-level support during the critical first weeks of treatment.

Patient Consensus: Patients note that Turkish treatments effectively halt disease progression but cannot reverse existing muscle damage. Families emphasise that securing oral medication involves strict genetic testing. It must also be paired with intensive physiotherapy in Turkey.

Patients qualifying for Zolgensma in Turkey must typically be infants under 2 years old. They must also have a 5q SMA diagnosis. The Turkish health system does not currently reimburse this gene therapy. Access requires private funding or individual Ministry of Health authorisation. This applies to cases with specific genetic markers.

• Age limit: Therapy is generally restricted to paediatric patients under 2 years of age.
• Genetic profile: Requires confirmed bi-allelic mutations in the SMN1 gene via genetic testing.
• Weight threshold: Infants must usually weigh under 13.5 kg for the intravenous infusion.
• Clinical status: Qualifying patients must not have permanent ventilation dependence or advanced muscle damage.

Bookimed Expert Insight: Turkish clinics like Memorial Şişli Hospital and Medipol University Pendik Hospital provide diagnostic infrastructure, including AI-supported 3 Tesla MRI and newborn intensive care. Zolgensma remains a self-funded option. However, specialists like Dr Siar Dursun use these tools to confirm SMN2 copy counts. This genetic data is vital. Patients with only one SMN2 copy require immediate, specialised Ministry of Health clearance. They need this clearance for any SMA intervention.

Patient Consensus: Families in Turkey emphasise the importance of confirming the SMN2 copy number immediately after diagnosis. This helps them navigate the complex approval process. They note that Nusinersen is state-covered. Zolgensma, however, often requires private fundraising or special legal pathways to access the one-time infusion.

Repetitive travel for Spinraza treatment in Turkey is mandatory. Patients must return for injections every 4 months following an initial loading phase. Specialist child neurologists, such as Dr Siar Dursun, perform these intrathecal injections in hospital settings. This helps manage Spinal Muscular Atrophy effectively.

• Maintenance schedule: Patients require maintenance doses three times annually to sustain motor function improvements.
• Clinical testing: Mandatory blood tests and clinical assessments occur before every lumbar puncture procedure.
• Specialised administration: Neuromuscular specialists must deliver the medication directly into the central nervous system.
• Accredited hubs: Treatment typically takes place in major cities at JCI-accredited facilities like Memorial Şişli Hospital.

Bookimed Expert Insight: Turkish university-affiliated hospitals serve over 350,000 patients annually. They often provide the most robust infrastructure for long-term SMA care. Facilities like Medipol University Pendik Hospital offer dedicated newborn intensive care units. This support is vital for international families. They manage the strict four-month injection cycles required for Spinraza.

Patient Consensus: Bringing documentation like wet-signed doctor letters simplifies customs for travellers. This is especially helpful when carrying related medications into Turkey. Patients emphasise keeping all medicines in original packaging. This avoids delays during their frequent treatment visits.

Turkish centres integrate multidisciplinary supportive care alongside medical therapy for Spinal Muscular Atrophy. Specialists provide respiratory monitoring, tailored physical therapy, and nutritional support. Centres like Memorial Şişli Hospital and Medipol University Pendik Hospital offer coordinated care. This includes genetic screening, orthopaedic management, and routine clinical reviews.

• Respiratory support: Non-invasive ventilation and secretion management prevent recurrent chest infections for patients.
• Physical therapy: Specialists like Dr Siar Dursun monitor motor development and muscle contractures.
• Nutritional care: Dietitians manage swallowing safety and provide specialised gastrostomy or PEG feeding plans.
• Orthopaedic tracking: Surgeons monitor spinal alignment to manage scoliosis with customised braces or surgery.
• Rehabilitation centres: Fizyomer Terapia provides intensive neuro-rehabilitation and physical therapy for chronic conditions.

Bookimed Expert Insight: Turkish university hospitals serve up to 350,000 patients annually. This high volume allows specialists to see complex cases. This includes patients with only one SMN2 copy. Families benefit from a longitudinal care model. In this model, clinical monitoring and physical therapy are mandatory for treatment continuation.

Patient Consensus: Patients note that physiotherapy is mandatory for treatment success in Turkey. Families emphasise that extensive genetic screening and regular specialist reviews are essential. They form key parts of the long-term care journey.

Turkey’s national Spinal Muscular Atrophy (SMA) screening program provides mandatory premarital carrier testing. It also provides universal newborn screening. Launched in 2021, the initiative uses molecular blood analysis to identify genetic risks early. This allows couples to access state-funded genetic counselling and IVF treatments before conception.

• Premarital screening: Mandatory blood tests for couples before marriage check for SMN1 gene deletions.
• Testing sequence: The male partner is tested first, followed by the female if required.
• Newborn screening: Heel prick tests identify affected infants within days of birth. This allows early intervention.
• Reproductive options: Carrier couples receive state-supported IVF with genetic diagnosis to prevent disease transmission.

Bookimed Expert Insight: Turkish university hospitals, such as Medipol, serve over 350,000 patients annually. They also specialise in complex neurology. Specialists like Dr Siar Dursun focus on neurodegenerative disorders and SMA specifically. This deep clinical volume means infants diagnosed through screening receive immediate care. They are treated by highly experienced paediatric neurologists.

Patient Consensus: Patients note the process is straightforward. However, they suggest allowing up to 2 months for results. The screening is recommended. Most appreciate that it provides clear reproductive choices. It also offers access to early genetic counselling in Turkey.